This article is a work in progress. If you have any questions, thoughts, or corrections, contact us.

Capital Sources

Insurance capital

Insurance capital

Insurance companies are among the largest investors in asset-backed finance. If you’re issuing rated term ABS or structured notes, insurance capital will likely be in your investor base. If you’re an originator trying to understand your cost of capital, or a fund structuring a rated note feeder, you need to understand how insurance companies evaluate and price ABF investments.

How to tell if your deal is insurance-placeable

Before you spend time courting insurance investors, run this quick assessment:

Can you get a rating? Most insurance companies require rated securities. If your deal can’t achieve at least a BBB- rating from a major agency, insurance placement will be difficult. Unrated deals require significant credit enhancement or a rated note feeder structure.

Is your asset class familiar? Insurance companies have strong appetite for auto loans, equipment leases, consumer loans, RMBS, CMBS, and CLOs. They have limited appetite for esoteric assets, short performance histories, or asset classes without established benchmarks.

Is your WAL appropriate? Insurance liabilities are long-dated. A deal with a 2-year WAL doesn’t match their ALM needs. Sweet spot is typically 3-10 years.

Is your ticket size sufficient? Most insurance companies have minimum check sizes of $25M-$50M. Below that threshold, the operational cost of analyzing and monitoring the position isn’t worth it. The sweet spot for insurance placement is $50M-$250M per investor.

Quick self-assessment:

  • Can you get an investment-grade rating? (Minimum BBB-)
  • Is WAL 3+ years?
  • Is ticket size $25M+?
  • Is the asset class established with performance benchmarks?

If you answered “no” to any of these, insurance capital will be challenging. Consider bank balance sheet or credit fund capital instead.

Why insurance companies are major ABF investors

Insurance companies run a spread-based business. They collect premiums, invest those premiums, and earn the spread between investment yield and liability cost. ABF offers several advantages over traditional fixed income:

Yield pickup. ABF typically offers 25-75 bps of additional spread over comparably-rated corporate bonds. For a large insurance portfolio, that yield pickup across billions of dollars is material.

Regulatory capital efficiency. The NAIC sets capital requirements for insurance company investments. Investment-grade structured products receive favorable capital treatment, particularly at the AAA and AA levels. See NAIC designations for details.

ALM matching. Insurance liabilities (annuities, life policies) are long-dated and require long-dated assets. ABF provides duration and predictable cash flows that match liability servicing needs. See ALM constraints for duration requirements.

Diversification. ABF has different risk characteristics than corporate credit. Consumer auto loans don’t default because a CEO made a bad acquisition. This diversification has value in a portfolio context.

Pricing expectations

Insurance investors are spread buyers. Here’s what to expect by rating level:

RatingTypical Spread (bps over Treasury)Notes
AAA75-125Tighter for prime auto, wider for esoteric
AA100-175Good demand from insurers at this level
A150-250Sweet spot for yield-focused insurers
BBB200-350NAIC-2 boundary, watch capital impact

Illustrative pricing. See pricing disclaimer.

What widens pricing

  • First-time issuer: +25-50 bps for track record risk
  • Novel asset class: +25-75 bps for unfamiliarity
  • Complex structure: +10-25 bps for analytical burden
  • Small deal size: +10-25 bps for illiquidity
  • Weak market conditions: Variable

What tightens pricing

  • Repeat issuer: Established issuers price inside first-timers
  • Strong asset class performance: Good sector performance supports tighter spreads
  • Large, liquid deal: Better secondary trading supports tighter pricing
  • Competitive auction: Multiple engaged investors create price tension

What insurance companies need in a structure

These aren’t negotiable. If you want insurance capital, your structure needs:

Rated securities. From S&P, Moody’s, Fitch, KBRA, or DBRS. Investment-grade (BBB- or better). Some insurers require dual ratings for large positions.

Bankruptcy-remote SPV. Standard securitization structure with true sale, non-consolidation opinion, and independent directors.

Appropriate credit enhancement. Senior tranches need enough subordination to achieve target ratings. This is determined by rating agency analysis, not negotiation.

Clean documentation. Prospectus or offering memorandum, complete rep and warranty framework, standard indenture provisions.

Ongoing reporting. Monthly or quarterly performance reports, trustee reports, and compliance certificates. Insurance investors expect to monitor their positions.

Duration that fits ALM. Most insurance mandates want 3-10 year WAL. Very short duration (under 2 years) or very long duration (over 15 years) limits the investor base.

Key insurance investor types

Large life insurers

These are the biggest buyers of ABF, with multi-billion dollar portfolios:

MetLife, Prudential, Principal, Lincoln: Traditional life insurers with large structured products teams. Appetite for investment-grade ABS across asset classes. Typical tickets $50M-$250M. Want 5-10 year WAL to match liability duration.

Athene, F&G Life, Global Atlantic: Insurance companies affiliated with private equity firms (Apollo, Blackstone, KKR respectively). More aggressive on yield, willing to go further into credit. Often have internal deal flow from their affiliates. See insurance-affiliated asset managers for details.

MassMutual, Northwestern Mutual, New York Life: Mutual insurers, generally more conservative. Appetite for high-quality senior tranches, less interest in yield pickup through credit risk.

P&C insurers

Property & casualty insurers have shorter-duration liabilities and different investment needs:

  • Shorter duration appetite (1-5 year WAL preferred)
  • Higher liquidity requirements
  • Smaller tickets typically
  • Examples: Travelers, Hartford, Chubb, AIG

Bermuda and offshore insurers

Bermuda-domiciled insurers operate under a different regulatory framework that may offer advantages for certain structures. See Bermuda insurance capital for details.

Captive insurance companies

Corporate-owned captives offer smaller tickets ($5M-$25M) with faster decisions but limited ABF expertise. See captive insurance for guidance.

What insurance placement adds to your timeline

Insurance capital is not a 2-week add to your deal process. Set realistic expectations:

Rating process: 6-12 weeks

  • Week 1-2: Engagement letter and fee negotiation
  • Week 3-6: Analytical review, data analysis, modeling
  • Week 6-8: Draft presale report, issuer review
  • Week 8-10: Rating committee
  • Week 10-12: Final rating and publication

Insurance allocation: 4-8 weeks

  • Week 1-2: Marketing, initial investor meetings
  • Week 2-4: Credit review and analysis at each insurer
  • Week 4-6: Investment committee presentations and approvals
  • Week 6-8: Allocation confirmation and documentation

Documentation and closing: 4-6 weeks

  • Week 1-2: Purchase agreement negotiation
  • Week 2-4: Documentation finalization
  • Week 4-6: NAIC designation confirmation, closing

Total realistic timeline: 4-6 months from decision to pursue insurance placement to funded capital. If someone tells you they can get insurance money in 6 weeks, they either have pre-existing commitments or are being optimistic.

Note: Run rating agency and insurance marketing processes in parallel where possible. Don’t wait for final ratings before starting insurance conversations. Preliminary ratings or rating agency feedback can support early-stage marketing.

Insurance company decision-making process

Understanding who you’re talking to and how decisions get made will help you navigate the process.

Who you’re talking to

Portfolio manager: Your day-to-day contact. Evaluates specific deals, runs analysis, presents to committee. PMs can champion your deal internally, but they don’t make final decisions alone.

Sector lead / asset class head: Sets strategy and risk appetite for the asset class. If they don’t like consumer unsecured, your consumer deal won’t get done regardless of how good it is.

CIO / investment committee: Final approval for significant positions. New asset classes or large tickets go here. Committee meets weekly or bi-weekly at most insurers.

Credit / risk management: Independent review that can veto deals. Their sign-off is required but they don’t source or champion deals.

What moves things faster

  • Prior experience: If the insurer has bought this asset class before, the path is easier
  • Clean story: Simple structure, established originator, straightforward asset class
  • Right timing: Hitting budget cycles, not competing with quarter-end crunch
  • Relationship: Existing relationship with the originator, manager, or placement agent

What slows things down

  • Novel asset class: First-time exposure requires education and more committee discussion
  • Complex structure: Multiple tranches, unusual waterfalls, non-standard features
  • Data gaps: Incomplete performance history, missing loan-level data
  • Timing: Year-end, when teams are focused on other priorities
  • No relationship: Cold outreach with no introduction or context

How to structure a deal for insurance placement

Rated note feeders

If you’re a credit fund with unrated ABF positions, you can access insurance capital through a rated note feeder:

The feeder SPV holds a diversified pool of ABF investments and issues rated notes against them. Insurance companies buy the rated notes. The fund retains the equity/residual.

When this works:

  • You have $200M+ of eligible positions to aggregate
  • Positions are diversified across originators and asset classes
  • You’re willing to accept structural leverage in exchange for cheaper capital

Cost and complexity: Expect $500K-$1M in setup costs (legal, rating agency fees, structuring). Ongoing costs include trustee, calculation agent, and annual rating surveillance. This only makes sense at scale.

Insurance-dedicated tranches

For term ABS issuance, structure your capital stack with insurance in mind:

AAA tranche: Size this for insurance appetite. Typical insurance company tickets are $50M-$250M, so a $500M deal might have 2-4 AAA investors.

AA/A tranches: Often placed with insurance as well, though tighter spreads mean some insurers prefer to go down the capital stack for yield.

BBB tranche: Still investment-grade, still insurance-eligible, but right at the NAIC-1/NAIC-2 boundary. Pricing matters here.

Subordinate/residual: Typically retained by the originator or held by credit funds.

When insurance capital works (and when it doesn’t)

Works well

  • Rated term ABS: Auto, consumer, equipment, student loan, RMBS
  • Investment-grade tranches: AAA through BBB
  • WAL 3-10 years: Matches liability duration
  • Established asset classes: Strong performance benchmarks
  • $50M+ tickets: Worth the operational burden
  • Predictable cash flows: Supports liability matching

Doesn’t work

  • Unrated deals: Need significant structuring to access
  • Sub-investment-grade: Requires different investor base
  • Very short duration: Doesn’t match ALM needs
  • Small tickets: Below operational threshold
  • Esoteric assets: Require education and longer diligence
  • High modification frequency: Operational complexity
  • Prepayment volatility: Extension/contraction risk challenges ALM

Deep dives


Key takeaways

  • Insurance capital requires rated, investment-grade securities. If you can’t get a BBB- rating, look elsewhere.
  • NAIC-1 vs. NAIC-2 designation (A- vs. BBB+) materially impacts capital charges and required spreads. The cliff effect at BBB+ is real.
  • ALM constraints drive duration requirements. Most life insurers want 5-8 year WAL; P&C wants 1-5 years.
  • Budget 4-6 months from engagement to funding. This is not quick capital.
  • Insurance-affiliated asset managers (Apollo/Athene, Blackstone/F&G, KKR/Global Atlantic) control $500B+ of captive capital.
  • Structure your capital stack with insurance ticket sizes in mind ($50M-$250M tranches for traditional insurers).